Low-density lipoprotein cholesterol outcomes post-non-PCSK9i lipid-lowering therapies in atherosclerotic cardiovascular disease and probable heterozygous familial hypercholesterolemia patients

References

• Centers for Disease Control and Prevention, National Center for Health Statistics [webpage on the Internet]Underlying Cause of Death 1999–2014: Multiple Cause of Death Files (1999–2014)2015 Available from: https://wonder.cdc.gov/ucd-icd10.htmlAccessed November 2, 2016
   Google Scholar
• KulloIJTrejo-GutierrezJFLopez-JimenezFA perspective on the New American College of Cardiology/American Heart Association guidelines for cardiovascular risk assessmentMayo Clin Proc20148991244125625131696
   PubMed Web of Science ®Google Scholar
• CatapanoALGrahamIDe BackerG2016 ESC/EAS Guidelines for the Management of DyslipidaemiasEur Heart J201637392999305827567407
   PubMed Web of Science ®Google Scholar
• NajamORayKKFamilial hypercholesterolemia: a review of the natural history, diagnosis, and managementCardiol Ther201541253825769531
   PubMedGoogle Scholar
• ReinerŽManagement of patients with familial hypercholesterolaemiaNat Rev Cardiol2015121056526076948
   PubMed Web of Science ®Google Scholar
• StoneNJRobinsonJGLichtensteinAH2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice GuidelinesJ Am Coll Cardiol20146325 Pt B2889293424239923
   PubMed Web of Science ®Google Scholar
• FoodyJMSajjanSGHuXHLoss of early gains in low-density lipoprotein cholesterol goal attainment among high-risk patientsJ Clin Lipidol20104212613221122640
   PubMed Web of Science ®Google Scholar
• NicholsGANagSChanWIntensity of lipid-lowering therapy and low-density lipoprotein cholesterol goal attainment among the elderly before and after the 2004 National Cholesterol Education Program Adult Treatment Panel III updateAm Heart J2007154355456017719305
   PubMed Web of Science ®Google Scholar
• FoodyJMTothPPTomassiniJEChanges in LDL-C levels and goal attainment associated with addition of ezetimibe to simvastatin, atorvastatin, or rosuvastatin compared with titrating statin monotherapyVasc Health Risk Manag2013971972724265554
   PubMedGoogle Scholar
• MorrisPBBallantyneCMBirtcherKKDunnSPUrbinaEMReview of clinical practice guidelines for the management of LDL-related riskJ Am Coll Cardiol201464219620625011724
   PubMed Web of Science ®Google Scholar
• LinISungJSanchezRJPatterns of Statin Use in a Real-World Population of Patients at High Cardiovascular RiskJ Manag Care Spec Pharm201622668569827231796
   PubMedGoogle Scholar
• Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in AdultsExecutive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)JAMA2001285192486249711368702
   PubMed Web of Science ®Google Scholar
• SabatineMSGiuglianoRPWiviottSDEfficacy and safety of evolocumab in reducing lipids and cardiovascular eventsN Engl J Med2015372161500150925773607
   PubMed Web of Science ®Google Scholar
• MarrettEZhaoCZhangNJLimitations of real-world treatment with atorvastatin monotherapy for lowering LDL-C in high-risk cardiovascular patients in the USVasc Health Risk Manag20141023724624851051
   PubMedGoogle Scholar
• RobinsonJGFarnierMKrempfMEfficacy and safety of alirocumab in reducing lipids and cardiovascular eventsN Engl J Med2015372161489149925773378
   PubMed Web of Science ®Google Scholar
• PhanKGomezYHElbazLDaskalopoulouSSStatin treatment non-adherence and discontinuation: clinical implications and potential solutionsCurr Pharm Des201420406314632424953391
   PubMed Web of Science ®Google Scholar
• CaspardHChanAKWalkerAMCompliance with a statin treatment in a usual-care setting: retrospective database analysis over 3 years after treatment initiation in health maintenance organization enrollees with dyslipidemiaClin Ther200527101639164616330301
   PubMed Web of Science ®Google Scholar
• ViraniSSWoodardLDAkeroydJMRamseyDJBallantyneCMPetersenLAIs high-intensity statin therapy associated with lower statin adherence compared with low- to moderate-intensity statin therapy? Implications of the 2013 American College of Cardiology/American Heart Association Cholesterol Management GuidelinesClin Cardiol2014371165365925324147
   PubMed Web of Science ®Google Scholar
• Writing CommitteeLloyd-JonesDMMorrisPB2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: A Report of the American College of Cardiology Task Force on Clinical Expert Consensus DocumentsJ Am Coll Cardiol20166819212527046161
   PubMed Web of Science ®Google Scholar
• DukeJDRyanPBSuchardMARisk of angioedema associated with levetiracetam compared with phenytoin: Findings of the observational health data sciences and informatics research networkEpilepsia2017588e101e10628681416
   PubMed Web of Science ®Google Scholar
• ShafrinJTebekaMGPriceKPatelCMichaudKThe economic burden of ACPA-positive status among patients with rheumatoid arthritisJ Manag Care Spec Pharm201824141129290168
   PubMed Web of Science ®Google Scholar
• MosnaimGArielyRDepietroMClinical Outcomes in Patients with Persistent Asthma by Attainment of Healthcare Effectiveness and Data Information Set (HEDIS) MeasuresPoster presented at: AAE Annual ConferenceJuly 20–22 2018Phoenix, AZ
   Google Scholar
• SommaKBhattDFonarowGGuideline adherence after ST-segment elevation versus non-ST segment elevation myocardial infarctionCirc Cardiovasc Interv201355654661
   Google Scholar
• SachdevaACannonCPDeedwaniaPCLipid levels in patients hospitalized with coronary artery disease: an analysis of 136,905 hospitalizations in Get With The GuidelinesAm Heart J2009157111111719081406
   PubMed Web of Science ®Google Scholar
• KrempfMSimpsonRJRameyDRPatient and physician factors influence decision-making in hypercholesterolemia: a questionnaire-based surveyLipids Health Dis2015144525985907
   PubMed Web of Science ®Google Scholar
• KotsevaKLessons from Euroaspire I, II, and III surveysHeart Metab2011503235
   Google Scholar
• KotsevaKEUROASPIRE InvestigatorsThe EUROASPIRE surveys: lessons learned in cardiovascular disease preventionCardiovasc Diagn Ther20177663363929302468
   PubMed Web of Science ®Google Scholar